Lenalidomide and Cetuximab in Treating Patients With Metastatic Colorectal Cancer

Stopped low accrual,loss of funding and results from EU study showing drug ineffective.

Conditions

• Colon Cancer
• Rectal Cancer

Interventions

• DRUG: lenalidomide
• BIOLOGICAL: cetuximab
• OTHER: mutation analysis
• OTHER: polymerase chain reaction
• GENETIC: polymorphism analysis

Sponsor

Case Comprehensive Cancer Center